These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38785930)

  • 1. Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia.
    Basingab FS; Alzahrani RA; Alrofaidi AA; Barefah AS; Hammad RM; Alahdal HM; Alrahimi JS; Zaher KA; Algiraigri AH; El-Daly MM; Alkarim SA; Aldahlawi AM
    Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.
    Migita K; Sho M; Shimada K; Yasuda S; Yamato I; Takayama T; Matsumoto S; Wakatsuki K; Hotta K; Tanaka T; Ito M; Konishi N; Nakajima Y
    Cancer; 2014 Mar; 120(6):808-17. PubMed ID: 24249528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8
    Liu Y; Wang L; Li Y; Zhong C; Wang X; Wang X; Xia Z; Liao J; Huang C; Mao C; Feng Y; Luo C; Mai W; Song H; Li H; Bao L; Chen D; Sheng Y; Zhang H; Wei X; Chen J; Yi W
    Cell Oncol (Dordr); 2024 Oct; 47(5):1779-1796. PubMed ID: 38809326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.
    Lichtenegger FS; Kondla I; Krempasky M; Weber AL; Herold T; Krupka C; Spiekermann K; Schneider S; Büchner T; Berdel WE; Wörmann BJ; Hiddemann W; Subklewe M
    Cancer Immunol Immunother; 2015 Dec; 64(12):1505-15. PubMed ID: 26377688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpesvirus entry mediator as a potential biomarker in breast cancer compared with conventional cytotoxic T‑lymphocyte‑associated antigen 4.
    Aldahlawi A; Basingab F; Alrahimi J; Zaher K; Pushparaj PN; Hassan MA; Al-Sakkaf K
    Biomed Rep; 2023 Aug; 19(2):56. PubMed ID: 37560313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD160 isoforms and regulation of CD4 and CD8 T-cell responses.
    El-Far M; Pellerin C; Pilote L; Fortin JF; Lessard IA; Peretz Y; Wardrop E; Salois P; Bethell RC; Cordingley MG; Kukolj G
    J Transl Med; 2014 Sep; 12():217. PubMed ID: 25179432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
    Hokuto D; Sho M; Yamato I; Yasuda S; Obara S; Nomi T; Nakajima Y
    Eur J Cancer; 2015 Jan; 51(2):157-65. PubMed ID: 25468715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of BTLA and HVEM Expression on Circulating CD4
    Song HF; Chen XJ; Tang PJ; Xu P; Huang ZY; Wang XF
    Viral Immunol; 2022 May; 35(4):291-302. PubMed ID: 35196150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.
    Han MZ; Wang S; Zhao WB; Ni SL; Yang N; Kong Y; Huang B; Chen AJ; Li XG; Wang J; Wang DH
    EBioMedicine; 2019 May; 43():159-170. PubMed ID: 30987862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia.
    Kang SH; Hwang HJ; Yoo JW; Kim H; Choi ES; Hwang SH; Cho YU; Jang S; Park CJ; Im HJ; Seo JJ; Kim N; Koh KN
    Anticancer Res; 2019 Oct; 39(10):5531-5539. PubMed ID: 31570447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Herpesvirus Entry Mediator Expression in Human Colorectal Liver Metastasis.
    Sasaki Y; Hokuto D; Inoue T; Nomi T; Yoshikawa T; Matsuo Y; Koyama F; Sho M
    Ann Surg Oncol; 2019 Nov; 26(12):3982-3989. PubMed ID: 31313042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between herpesvirus entry mediator and HSV-2 glycoproteins mediates HIV-1 entry of HSV-2-infected epithelial cells.
    Hu K; He S; Xiao J; Li M; Luo S; Zhang M; Hu Q
    J Gen Virol; 2017 Sep; 98(9):2351-2361. PubMed ID: 28809154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.
    Cai G; Anumanthan A; Brown JA; Greenfield EA; Zhu B; Freeman GJ
    Nat Immunol; 2008 Feb; 9(2):176-85. PubMed ID: 18193050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
    Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
    J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression.
    Ren S; Tian Q; Amar N; Yu H; Rivard CJ; Caldwell C; Ng TL; Tu M; Liu Y; Gao D; Ellison K; Suda K; Rozeboom L; Rivalland G; Mitchell P; Zhou C; Hirsch FR
    Lung Cancer; 2018 Nov; 125():115-120. PubMed ID: 30429008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.
    Šedý JR; Balmert MO; Ware BC; Smith W; Nemčovičova I; Norris PS; Miller BR; Aivazian D; Ware CF
    J Biol Chem; 2017 Dec; 292(51):21060-21070. PubMed ID: 29061848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
    Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes virus entry mediator, which decreases in HIV infection, can enhance the suppressive activity of regulatory T cell and predict recovery of CD4+T-cells during HAART.
    Fu Y; Zhang Z; Jiang Y; Zhang J; Zhao W; Liao C; Shang H
    Curr HIV Res; 2015; 13(2):151-9. PubMed ID: 25892413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1
    Del Rio ML; de Juan CY; Roncador G; Caleiras E; Álvarez-Esteban R; Pérez-Simón JA; Rodriguez-Barbosa JI
    Front Immunol; 2023; 14():1113858. PubMed ID: 37033927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer.
    Tsang JYS; Chan KW; Ni YB; Hlaing T; Hu J; Chan SK; Cheung SY; Tse GM
    Ann Surg Oncol; 2017 Dec; 24(13):4042-4050. PubMed ID: 28612127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.